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critically ill patients: The VITA-TRACE surves u m m a r y
Background & aims: Despite the presumed importance of preventing and treating micronutrient and
mineral deficiencies, it is still not clear how to optimize measurement and administration in critically ill
patients. In order to design future comparative trials aimed at optimizing micronutrient and mineral
management, an important first step is to gain insight in the current practice of micronutrient, phosphate
and magnesium monitoring and administration.
Methods: Within the metabolism-endocrinology-nutrition (MEN) section of the European Society of
Intensive Care Medicine (ESICM), the micronutrient working group designed a survey addressing current
practice in parenteral micronutrient and mineral administration and monitoring. Invitations were sent
by the ESICM research department to all ESICM members and past members.
Results: Three hundred thirty-four respondents completed the survey, predominantly consisting of
physicians (321 [96.1%]) and participants working in Europe (262 [78.4%]). Eighty-one (24.3%)pean Society of Intensive Care Medicine; ICU, Intensive care unit; MEN, Metabolism-Endocrinology-Nutrition; PN,
l.
ellular and Molecular Medicine, Laboratory of Intensive Care Medicine, Belgium. Herestraat 49, 3000, Leuven, Belgium.
Casaer).
Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
et al., Monitoring and parenteral administration of micronutrients, phosphate and magnesium in
y, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.06.005
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critically ill patients: The VITA-TRACE surverespondents reported to monitor micronutrient deficiencies through clinical signs and/or laboratory
abnormalities, and 148 (44.3%) reportedly measure blood micronutrient concentrations on a routine
basis. Two hundred ninety-two (87.4%) participants provided specific data on parenteral micronutrient
supplementation, of whom 150 (51.4%) reported early administration of combined multivitamin and
trace element preparations at least in selected patients. Among specific parenteral micronutrient
preparations, thiamine (146 [50.0%]) was reported to be the most frequently administered micronutrient,
followed by vitamin B complex (104 [35.6%]) and folic acid (86 [29.5%]). One hundred twenty (35.9%) and
113 (33.8%) participants reported to perform daily measurements of phosphate and magnesium,
respectively, whereas 173 (59.2%) and 185 (63.4%) reported to routinely supplement these minerals
parenterally.
Conclusion: The survey revealed a wide variation in current practices of micronutrient, phosphate and
magnesium measurement and parenteral administration, suggesting a risk of insufficient prevention,
diagnosis and treatment of deficiencies. These results provide the context for future comparative studies,
and identify areas for knowledge translation and recommendations.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Micronutrients, consisting of vitamins and trace elements, are
essential substances needed in minuscule amounts to ensure
proper functioning of crucial physiological and metabolic processes
[1e3]. In addition, phosphate and magnesium although generally
not labelled as micronutrient given their daily-required doses
exceeding 100 mg are two essential minerals [2,3]. Given their
important role in maintaining homeostasis, severe deficiencies of
micronutrients, phosphate and magnesium are potentially life-
threatening [2,4,5]. Critically ill patients are at increased risk of
developing such deficiencies due to illness-induced decreased
intake, increased losses, drug interactions and potentially higher
needs (Table 1) [1,2,4,6e8]. Moreover, the risk of developing a
deficiency may be increased by the recent shift in feeding practices.
Indeed, feeding guidelines based on recent large randomized
controlled trials (RCTs) no longer support high-dose macronutrient
feeding in the early phase of critical illness [9]. This delayed
macronutrient administration may unintentionally reduce micro-
nutrient, phosphate and magnesium provision in the early phase,
potentially inducing or aggravating deficiencies. Since symptoms of
micronutrient deficiencies, as well as of hypophosphatemia and
hypomagnesemia are non-specific in the context of critical illness
(Table 2), deficiencies can easily be overlooked [4,6]. Additionally,
initiation of artificial feeding may render pre-existing deficiencies
symptomatic. Indeed, refeeding acutely increases the need for
certain minerals and micronutrients such as phosphate and thia-
mine, whereby rapid initiation of artificial feeding may lead to a
potentially lethal refeeding syndrome [3]. Clinical signs of refeed-
ing syndrome include cardiac arrhythmias, cardiogenic shock,
muscle weakness and lactic acidosis. New-onset hypo-
phosphatemia has been put forward as predominant biochemical
feature of refeeding syndrome [10,11].
Despite the presumed importance of preventing and treating
micronutrient and mineral deficiencies, it is still not clear how to
optimize measurement and administration in critically ill patients,
since large observational and interventional studies are lacking [1].
Blood micronutrient and mineral concentrations may be affected
by exogenous infusion and redistribution, particularly related to
inflammation [12], and thus not necessarily reflect tissue levels [8].
The need to separately administer micronutrients depends in part
on the route of feeding [6]. Indeed, commercially available enteral
nutrition formulations contain micronutrients, whereby their
provision depends on the energy intake achieved [13]. In contrast,
commercially available parenteral nutrition solutions notet al., Monitoring and paren
y, Clinical Nutrition, https://dcontaining any micronutrients due to instabilities necessitate
separate supplementation in patients receiving exclusive paren-
teral nutrition [9]. The optimal speed of parenteral micronutrient
infusion is also a matter of debate. Direct sunlight and certain trace
elements may degrade vitamins, particularly A, C and E [14,15]. A
more rapid infusion of micronutrients could be an approach to
overcome such degradation, but may transiently expose patients to
supraphysiological concentrations and consequently enhance uri-
nary loss of water-soluble micronutrients, which is concentration-
dependent [16,17].
To gain more insight in the current practice regarding micro-
nutrient, phosphate and magnesium monitoring and parenteral
administration, the micronutrient working group within the
Metabolism-Endocrinology-Nutrition (MEN) section of the Euro-
pean Society of Intensive Care Medicine (ESICM) designed a survey.
The results will inform the design of comparative studies and may
reveal discrepancies with existing guidelines.2. Materials and methods
Nutritional experts with a special interest for micronutrients
were invited to join the micronutrient working group. During an
initial face-to-face meeting, the working group defined the scope of
the survey and the target audience. Thereafter, the questionnaire
was constructed, followed by adjustments through email commu-
nication until consensus was reached, optimizing content validity.
Technical issues and timing were discussed during a final plenary
meeting. The questionnaire was converted into an online survey
with the web application Limesurvey (version 2.00, Hamburg,
Germany) on a KU Leuven server. Only the principal investigators
could make changes to the survey. To optimize face validity and
unambiguous interpretation, the survey was tested by a focus
group, consisting of intensive care specialists (n ¼ 10), after which
final adjustments were made. Subsequently, the survey was sent to
the expert group for final approval and discussion on which ques-
tions should be mandatory.
The full questionnaire is available as online supplement (see
additional file 1). The survey consisted of two main sections. The
first section addressed respondent's characteristics including their
working environment and general nutritional and metabolic
management. The second section comprised specific questions
about routine monitoring and parenteral administration of micro-
nutrients, phosphate and magnesium. All fields were mandatory,
except for ancillary questions regarding specific details on indi-
vidual micronutrients (see additional file 1). When inquiring timingteral administration of micronutrients, phosphate and magnesium in
oi.org/10.1016/j.clnu.2020.06.005
Table 2
Clinical and laboratory signs of a micronutrient, phosphate and/or magnesium
deficiency.
Anemia and other cytopenias
Hypokalemia
Hypocalcemia
Metabolic disturbances (lactic acidosis, hyperlipidemia, hyperglycemia)
Neurological and cognitive deficits
Cardiac dysfunction
Muscle weakness and myopathy
Osteoporosis/bone pain
Rickets and osteomalacia
Immune dysfunction
Skin lesions and delayed wound healing
Glossitis and (angular) cheilitis
Growth and developmental disorders
Table 1
Risk factors for developing a micronutrient, phosphate and/or magnesium deficiency.
Inadequate intake or uptake Increased losses and consumption Drug interaction (with single micronutrients)
- Prolonged starvation
- Unbalanced diet
- Bariatric surgery
- Malabsorption syndromes
(celiac disease, inflammatory bowel disease,
chronic pancreatitis, cystic fibrosis, short bowel)
- Alcoholism
- Chronic liver disease
- Kidney dysfunction/failure
- Drugs (proton pump inhibitors, H2-receptor antagonists,
cholestyramine, broad spectrum antibiotics,
metformin, thyroxin, ….)
- Large burn wounds
- Meno(metro)rrhagia
- Prolonged inflammation and oxidative stress
- Increased urinary loss
(diuretics, hyperparathyroidism,
tubular dysfunction)
- Continuous renal replacement therapy
- Gastrointestinal fistula, chylous leak
- Isoniazid
- Phenobarbital
- Phenytoin
- Penicillamine
- Theophylline
- Tricyclic antidepressants
W. Vankrunkelsven et al. / Clinical Nutrition xxx (xxxx) xxx 3of particular events, day 1 was defined as the day of intensive care
unit (ICU) admission.
The survey was active from October 1, 2018 until December 10,
2018. The invitation was sent by the ESICM research department to
all ESICM members and past members on October 1, 2018. Re-
spondents could only access the survey with the use of a unique
token, preventing double participation. Non-respondents received
a reminder on November 7 and November 26, 2018. The list of
recipients and allocated tokens was not available to the researchers
and was destroyed after completion of the survey. Participants had
the possibility to save partially completed surveys and resume later.
However, only fully completed surveys were available to the re-
searchers and were included in the analyses. No personal datawereTable 3
Demographic characteristics of the respondents.
n (%)
Profession
Physician 321 (96.1%)
Nutritionist 7 (2.1%)
Nurse 5 (1.5%)
Clinical pharmacist 1 (0.3%)
Type of hospital
Academic 208 (62.3%)
Non-academic 126 (37.7%)
Type of ICU
Surgical 35 (10.5%)
Medical 27 (8.1%)
Mixed 267 (79.9%)
Burn/trauma 5 (1.5%)
ICU population
Adults 292 (87.4%)
Children 16 (4.8%)
Mixed 26 (7.8%)
Please cite this article as: Vankrunkelsven W et al., Monitoring and paren
critically ill patients: The VITA-TRACE survey, Clinical Nutrition, https://dsaved and the answers could not be linked to the token used to
access the survey, ensuring anonymity. The surveywas endorsed by
ESICM.
The Ethical Committee Research UZ/KU Leuven provided a
favorable advice for the survey (S61822). The information provided
in the survey was collected anonymously and did not contain
personal data, hence falling outside the scope of the General Data
Protection Regulation.
Data are presented as numbers and percentages, or as median
(interquartile range). Percentages are expressed relative to the total
number of respondents, unless indicated otherwise. Analyses were
performed in JMP (version 14, SAS, Cary, North Carolina).
3. Results
3.1. General characteristics of the respondents
Three hundred thirty-four respondents completed the survey
of whom 321 (96.1%) were physicians, 7 (2.1%) nutritionists, 5
(1.5%) nurses and 1 (0.3%) clinical pharmacist (Table 3). The re-
ported working environment was predominantly European (262
[78.4%]), academic (208 [62.3%]), mixed surgical/medical ICU
(267 [79.9%]), and only treating adult patients (292 [87.4%])
(Table 3 þ Fig. 1A). Within Europe, most countries were repre-
sented, with eleven countries having more than ten respondents
(Fig. 1B).
Two hundred twenty-seven (68.0%) participants reported to
have access to sources documenting the presumed requirements of
trace elements and vitamins in critically ill patients. The most
commonly reported sources were guidelines (N ¼ 170/227 [74.9%])
and analysis of the literature (N ¼ 48/227 [21.1%]). One hundred
sixty-eight (50.3%) respondents reported to have access to sources
documenting the normal range of blood concentrations of trace
elements and vitamins. The most commonly reported sources were
guidelines (N ¼ 87/168 [51.8%]) and analysis of the literature
(N ¼ 36/168 [21.4%]).
3.2. General nutritional and metabolic management
Full enteral nutrition was reported to be reached in the
average patient after a median of 3 (2e4) days, with a range
from 1 to 10 days (Fig. 2). When less than 60% of caloric intake
is provided by enteral nutrition, parenteral nutrition was re-
ported to be initiated median at day 5 (3e7; total range 1e21).
Three hundred nine (92.5%) participants reported to have a
protocol for blood glucose control, with varying targets (Fig. 3).
Parenteral micronutrient supplementation in patients receiving
no or insufficient artificial nutrition is initiated median at day 3teral administration of micronutrients, phosphate and magnesium in
oi.org/10.1016/j.clnu.2020.06.005
Fig. 1. Geographical location of the respondents. Continent (A) and European country (B) where respondents reported their intensive care unit is located.
W. Vankrunkelsven et al. / Clinical Nutrition xxx (xxxx) xxx4(1e5; total range 1e999) for mixtures of water-soluble vita-
mins, day 3 (2e6; total range 1e999) for mixtures of lipid-
soluble vitamins and day 3 (2e7; total range 1e999) for trace
element preparations.3.3. Micronutrient monitoring
Eighty-one (24.3%) respondents reported to monitor micro-
nutrient deficiencies through clinical signs and/or laboratory ab-
normalities. The most frequently monitored laboratory
abnormalities were anemia with or without other cytopenia (24
[7.2%]), followed by metabolic acidosis (13 [3.9%]). Among the
clinical signs, skin lesions (46 [13.8%]), neurological signs (43
[12.9%]), decreased wellbeing and weakness (40 [12.0%]), and car-
diac signs (32 [9.6%]) were most frequently monitored (Table 4).
One hundred forty-eight (44.3%) respondents reported to routinely
measure the blood concentrations of selected micronutrients to
detect deficiencies. The 10 most frequently reported routine mea-
surements and their respective measurement frequencies are
depicted in Fig. 4. The three most frequently reported measure-
ments were iron (97 [29.0%]), folate (65 [19.5%]) and vitamin B12
(58 [17.4%]).Please cite this article as: Vankrunkelsven W et al., Monitoring and paren
critically ill patients: The VITA-TRACE survey, Clinical Nutrition, https://d3.4. Parenteral micronutrient administration
Two hundred ninety-two (87.4%) participants provided data on
specific micronutrient supplementation, of whom 150 (51.4%)
reportedly provided early parenteral combined multivitamin and
trace element preparations at least in selected patients. Seventy-
eight (26.7%) respondents reported to parenterally supplement all
patients and 63 (21.6%) reported to only supplement selected pa-
tients (Table 5). Within the specific parenteral micronutrient
preparations, thiamine was reported as most frequently supple-
mented (146 [50.0%]), followed by vitamin B complex (104 [35.6%]),
folic acid (86 [29.5%]), vitamin B12 (85 [29.1%]), vitamin C (83
[28.4%]) and iron (68 [23.3%]) (Fig. 5). Respondents supplementing
specific parenteral micronutrient preparations most often did so in
selected patients. Themodality of parenteral administration of both
combined and specific micronutrient preparations was highly
variable (Table 6).3.5. Phosphate and magnesium monitoring and administration
One hundred twenty (35.9%) and 113 (33.8%) respondents re-
ported to daily measure phosphate and magnesium, respectively,
whereas 75 (22.5%) and 85 (25.4%) reported not to routinelyteral administration of micronutrients, phosphate and magnesium in
oi.org/10.1016/j.clnu.2020.06.005
Fig. 2. Timing of enteral and parenteral nutrition, and parenteral micronutrient administration. (A) Average day in the intensive care unit (ICU) at which a respondent reported
to reach full enteral nutrition (EN). (B) Average day at which a respondent reported to initiate parenteral nutrition (PN) if EN is insufficient (<60% of target caloric intake). (CeE)
Average day at which a respondent reported to initiate parenteral water-soluble vitamins (C), lipid-soluble vitamins (D) or trace elements (E) in patients receiving insufficient
enteral nutrition and no parenteral nutrition. Data presented as cumulative number of respondents. ICU day 1 represents the day of ICU admission.
Fig. 3. Blood glucose control. Upper and lower blood glucose target. Boxes indicate
median and interquartile range, whiskers 10th and 90th percentile.
W. Vankrunkelsven et al. / Clinical Nutrition xxx (xxxx) xxx 5measure phosphate and magnesium, or to measure not more than
once a week (Table 7). Of the 292 respondents providing data on
parenteral micronutrient and mineral supplementation, 173
(59.2%) and 185 (63.4%) reported to regularly supplement phos-
phate and magnesium, respectively. The modality of parenteral
phosphate and magnesium administration considerably differed
among respondents (Table 7).3.6. Practical aspects and protocols regarding micronutrient
management
Most of the respondents (276 [82.6%]) reported that the
attending intensivist is in charge for the prescription of parenteral
micronutrients, followed by a dedicated internal nutritional team
(n ¼ 27, [8.1%]) and a dedicated intensivist with extra expertise
(n ¼ 17, [5.1%]) (Table 8). One hundred nineteen (35.6%) re-
spondents reported to have a protocol for the administration of
parenteral micronutrients. Of these protocols, 66 (55.5%) are
designed to prevent inactivation of selected vitamins by daylight,
and 58 (48.8%) take incompatibilities between some micro-
nutrients into account. Seventy-six (22.8%) respondents reported toPlease cite this article as: Vankrunkelsven W et al., Monitoring and paren
critically ill patients: The VITA-TRACE survey, Clinical Nutrition, https://dhave a protocol to prevent omission of micronutrients in parenteral
nutrition. One hundred seventy (50.9%) reported to prescribe
enteral or parenteral micronutrients on top of full enteral nutrition
in some occasions.
4. Discussion
The VITA-TRACE survey inquired current practices regarding
monitoring and parenteral administration of micronutrients and
minerals in the critically ill. The results suggest a wide variation in
clinical practice. Indeed, while some respondents reported to not
routinely measure bloodmicronutrient, phosphate andmagnesium
concentrations, others reported to perform selective measure-
ments on a daily basis and to have structured protocols. Similarly,
the timing and indication of parenteral micronutrient, phosphate
and magnesium supplementation differed considerably, and the
presence and content of protocols for micronutrient administration
varied. Most respondents reported not aiming to reach the full
caloric target in the first days of critical illness and avoiding early
parenteral nutrition. The vast majority of participants were physi-
cians with more than 10 years of expertise, mainly working in
mixed ICUs and treating only adult critically ill patients. Most
participants resided in Europe, and most European countries were
sufficiently represented in the survey. Hence, the results appear
generalizable and reflective for real-life practices in Europe.
The results provide the basis for future comparative studies, as
planned by the micronutrient working group of ESICM. Indeed,
since there are only limited data on the daily requirements of
micronutrients, phosphate and magnesium in general ICU patients,
future studies should investigate existing practices from a phar-
macological perspective, and study effects on patient-centered and
health-economic endpoints [1]. The variability in micronutrient
measurements could be partially related to an uncertainty to what
extent decreases in selected micronutrient concentrations are
related to inflammation-induced redistribution, and whether this
requires treatment or not. Apart from studying this topic, future
studies should examine how individual micronutrient and mineral
administration can be optimized, in order to prevent potential
inactivation of certain micronutrients by slow administration and
long storage, and potential rapid renal losses associated with bolusteral administration of micronutrients, phosphate and magnesium in
oi.org/10.1016/j.clnu.2020.06.005
Table 4
Monitored clinical signs and laboratory abnormalities of micronutrient, phosphate and magnesium deficiencies.
Symptom n (%)
Laboratory abnormalities 49 (14.7%)
Anemia and/or other cytopenia 24 (7.2%)
Metabolic acidosis 13 (3.9%)
Other (altered liver enzymes or function, hypoalbuminemia, renal impairment, hypertriglyceridemia,
increased INR, hyperammonemia, thyroid hormone, uremia)
12 (3.6%)
Skin lesions (dermatitis, dry, fragile skin; delayed wound healing; decubitus) 46 (13.8%)
Neurological signs 43 (12.9%)
Peripheral symptoms (muscle cramps, abnormal reflexes, paresthesia, …) 20 (6.0%)
Central nervous system (delirium, altered consciousness, convulsions, ataxia) 14 (4.2%)
Undefined 9 (2.7%)
Decreased general wellbeing and weakness 40 (12.0%)
Cardiac signs (arrhythmias, cardiac failure, edema) 32 (9.6%)
Mucosal lesions (mucositis, glossitis, angular cheilitis) 18 (5.4%)
Hair and nail lesions 17 (5.1%)
Bleeding diathesis 12 (3.6%)
Gastrointestinal disorders (diarrhea, vomiting, ileus) 9 (2.7%)
Ocular abnormalities (keratitis, Bitot's spots, night blindness, xerophthalmia) 7 (2.1%)
Osteoporosis 2 (0.6%)
Fig. 4. Top ten most frequent micronutrient measurements. Percentage of re-
spondents and the frequency at which they reported to measure selected micro-
nutrients. Only the 10 most frequent measurements are displayed. Percentages are
expressed relative to the total number of respondents.
Table 5
Parenteral supplementation of mixed vitamins and trace elements.
Early mixed vitamin supplementationa
of whichb in all patient
in selected p
No early mixed vitamins supplementation
Early trace elements supplementation
of whichc in all patient
in selected p
No early trace element supplementation
Early mixed vitamins þ trace elements supplementation
of whichd in all patient
in selected p
No early mixed vitamins þ trace elements supplementation
Percentages were calculated relative to the number of participants providing data on su
a Mixed vitamins¼mixed vitamins preparation, or combination of mixed water-solubl
C þ vitamin D þ vitamin E.
b Data missing in 6 respondents.
c Data missing in 9 respondents.
d Data missing in 9 respondent.
W. Vankrunkelsven et al. / Clinical Nutrition xxx (xxxx) xxx6
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critically ill patients: The VITA-TRACE survey, Clinical Nutrition, https://dinfusions [14e17]. In addition, the optimal frequency of selected
micronutrient measurements remains to be established, taking into
consideration cost-effectiveness, and blood losses due to frequent
blood sampling.
Iron, folate and vitamin B12 were the three micronutrients re-
ported to be most frequently measured. Although speculative, this
could be explained by the high frequency of anemia in critically ill
patients [18]. Diagnosing iron deficiency is complex in critically ill
patients, however, and we did not inquire whether additional
measurements regarding iron status were performed concomi-
tantly [19]. Not surprisingly, iron, folic acid and vitamin B12 were
among the six most often parenterally supplemented micro-
nutrients, mostly in selected patients. Vitamin B complex, thiamine
and vitamin C completed the top six of most parenterally supple-
mented micronutrients. Thiamine administration is likely used in
patients at risk to prevent Wernicke encephalopathy and cardiac
failure [20]. Selective administration of vitamin C and thiaminen (%)
209 (71.6%)
s 118 (40.4%)
atients 85 (29.1%)
83 (28.4%)
168 (57.5%)
s 89 (30.5%)
atients 70 (24.0%)
124 (42.5%)
150 (51.4%)
s 78 (26.7%)
atients 63 (21.6%)
142 (48.6%)
pplementation (292/334, 87.4%).
e and lipid-soluble vitamin preparations, or vitamin Aþ vitamin Bmixtureþ vitamin
teral administration of micronutrients, phosphate and magnesium in
oi.org/10.1016/j.clnu.2020.06.005
Fig. 5. Top ten most frequent specific parenteral micronutrient supplements.
Percentage of respondents parenterally supplementing specific micronutrient formu-
lations. Only the 10 most supplemented preparations are displayed. Percentages are
expressed relative to the number of respondents providing data on parenteral
micronutrient supplementation (N ¼ 292).
Table 6
Method of parenteral micronutrient supplementation.
Added to IV fluid bag, n (%)a Separate bolus, n (%)a Separate continuous infusion, n (%)a Unknown, n (%)a
Combined water- and lipid-soluble vitamin
preparations (N ¼ 144)
69 (47.9%) 34 (23.6%) 17 (11.8%) 24 (16.7%)
Combined water-soluble vitamin preparations (N ¼ 137) 73 (53.3%) 26 (19.0%) 19 (13.9%) 19 (13.9%)
Combined lipid-soluble vitamin preparations (N ¼ 107) 60 (56.1%) 15 (14.0%) 17 (15.9%) 15 (14.0%)
Combined trace element preparations (N ¼ 168) 99 (58.9%) 26 (15.5%) 19 (11.3%) 24 (14.3%)
Thiamine (B1) (N ¼ 146) 23 (15.8%) 90 (61.6%) 9 (6.2%) 24 (16.4%)
Vitamin B complex (N ¼ 104) 23 (22.1%) 51 (49.0%) 8 (7.7%) 22 (21.2%)
Folic acid (N ¼ 86) 5 (5.8%) 54 (62.8%) 5 (5.8%) 22 (25.6%)
Vitamin B12 (N ¼ 85) 5 (5.9%) 58 (68.2%) 7 (8.2%) 15 (17.6%)
Vitamin C (N ¼ 83) 16 (19.3%) 43 (51.8%) 10 (12.0%) 14 (16.9%)
Iron (N ¼ 68) 5 (7.4%) 37 (54.4%) 8 (11.8%) 18 (26.5%)
Vitamin D (N ¼ 59) 2 (3.4%) 40 (67.8%) 3 (5.1%) 14 (23.7%)
Zinc (N ¼ 51) 16 (31.4%) 12 (23.5%) 8 (15.7%) 15 (29.4%)
Selenium (N ¼ 45) 12 (26.7%) 11 (24.4%) 6 (13.3%) 16 (35.6%)
Vitamin E (N ¼ 20) 2 (10.0%) 9 (45.0%) 1 (5.0%) 8 (40.0%)
IV: intravenous.
a Percentage calculated relative to the number of respondents supplementing the respective micronutrient.
Table 7
Phosphate and magnesium.
n (%) n (%)
Phosphate Magnesium
Measurement blood concentration
Never 22 (6.6%) 32 (9.6%)
Once a week 53 (15.9%) 53 (15.9%)
2 or 3 times a week 96 (28.7%) 98 (29.3%)
More than 3 times a week 43 (12.9%) 38 (11.4%)
Once a day 118 (35.3%) 111 (33.2%)
More than once a day 2 (0.6%) 2 (0.6%)
Regular parenteral supplementation of phosphate and magnesiuma 173 (59.2%) 185 (63.4%)
All patients 38 (13.0%) 55 (18.8%)
Specific indications 127 (43.5%) 120 (41.1%)
Unknown 8 (2.7%) 10 (3.4%)
Method of parenteral administrationb
Separate continuous infusion 61 (35.3%) 45 (24.3%)
Separate bolus 57 (32.9%) 71 (38.4%)
Added to IV-fluid bag 33 (19.1%) 42 (22.7%)
Unknown 22 (12.7%) 27 (14.6%)
a Percentage calculated relative to the number of respondents providing data on micronutrient supplementation.
b Percentage calculated relative to the number of respondents supplementing phosphate or magnesium respectively.
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despite the lack of conclusive evidence [21e23].
The survey identified clear areas for knowledge translation.
Indeed, a considerable fraction of respondents reported to notPlease cite this article as: Vankrunkelsven W et al., Monitoring and paren
critically ill patients: The VITA-TRACE survey, Clinical Nutrition, https://dregularly monitor neither parenterally administer micro-
nutrients, phosphate and magnesium. Furthermore, the reported
global practice of tolerating a macronutrient deficit in the first
days of critical illness, in line with recent feeding guidelines [9],
may provoke or aggravate a deficit when micronutrients, phos-
phate and magnesium are not monitored or are equally
restricted. This constellation is potentially dangerous, since
symptoms of micronutrient deficiencies, hypophosphatemia,
hypomagnesemia and refeeding syndrome are non-specific and
potentially life-threatening when left untreated [4]. In this re-
gard, in critically ill patients developing refeeding syndrome, as
defined by new-onset hypophosphatemia after initiation of
artificial nutrition, a large RCT has found that temporarily
restricting macronutrient intake while correcting micronutrient
deficiencies and hypophosphatemia improved survival as
compared to continuing and increasing macronutrient intake
[10]. When phosphate is not measured, however, it is unlikelythat this life-saving strategy would be implemented. Tradition-
ally, several factors have been considered risk factors for devel-
oping refeeding syndrome, including pre-existing malnutrition
and prolonged starvation [24]. However, a recent observationalteral administration of micronutrients, phosphate and magnesium in
oi.org/10.1016/j.clnu.2020.06.005
Table 8
Practical aspects and protocols regarding micronutrient management.
n (%)
Responsible for prescribing parenteral micronutrients
Intensivist 276 (82.6%)
Dedicated internal nutritional team 27 (8.1%)
Dedicated intensivist with nutritional expertise 17 (5.1%)
Dedicated external nutritional team 8 (2.4%)
Pharmacist 4 (1.2%)
Nurse 2 (0.6%)
Protocol in place for parenteral micronutrient administration 119 (35.6%)
Which prevents inactivation from daylighta 66 (55.5%)
Which takes incompatibilities into accounta 58 (48.8%)
Protocol to avoid omission of micronutrients in patients receiving parenteral nutrition 76 (22.8%)
Prescribe enteral or parenteral micronutrients on top of full enteral nutrition in some occasions 170 (50.9%)
a Percentage calculated relative to the number of respondents with a protocol in place for parenteral micronutrient administration.
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by upon-admission risk factors [11]. This underscores the po-
tential importance of measuring phosphate on a routine basis in
critically ill patients.
Although speculative, potential differences in parenteral
micronutrient administration could explain the divergent impact of
artificial feeding on clinical outcome across recent nutritional RCTs
in critically ill and hospitalized patients, apart from differences in
patient population, energy and protein target, feeding route, and
relative macronutrient content [25e35]. Indeed, in contrast to
several RCTs in which micronutrient and mineral administration
was protocolized in both study arms [25,28,30e33], other RCTs did
not protocolize micronutrient management [26,34] or only advised
physicians to prescribe micronutrients in the intervention arm
[27,29,35]. Consequently, in RCTs without protocolized and com-
parable micronutrient management in both arms, it remains un-
clear whether the results are explained by differences in
macronutrient intake, or by insufficient prevention and detection
of micronutrient/mineral deficiencies and refeeding syndrome in
one of the study arms [36].
The study was designed through collaboration between multi-
ple experts in the field of nutritional management of critically ill
patients. Yet, the study inherently has limitations. The number of
respondents was relatively low. However, there was a good distri-
bution across Europe and the unique token sent by ESICM pre-
vented double participation. Moreover, most participants were
experienced and worked in an academic center, and one could
speculate that a considerable fractionmay have a particular interest
in the topic. Hence, we expect that this potential bias would more
likely underestimate rather than overestimate potential in-
adequacies in current practice. A second limitation relates to the
survey itself, whereby we could only inquire the intentions of the
respondent. Indeed, previous research has shown that the admin-
istered macronutrient intake of critically ill patients often does not
correspond to what is prescribed [37]. Hence, we do not know
whether the reported micronutrient practice truly reflects the
clinical practice of the respondent. However, also for this limitation,
we are convinced this potential bias would underestimate rather
than overestimate the need for knowledge translation. Third, not all
participants provided data on specific micronutrient supplemen-
tation, whereby a blank answer may mean either no supplemen-
tation or missing data. However, by calculating the percentage of
respondents relative to the number of participants who provided at
least one answer (i.e. reported to provide at least one specific
micronutrient), this potential bias would only underestimate the
real percentage of participants not providing early parenteral
micronutrients. Fourth, for themajority of questions, we focused on
parenteral supplementation of micronutrients. SincePlease cite this article as: Vankrunkelsven W et al., Monitoring and paren
critically ill patients: The VITA-TRACE survey, Clinical Nutrition, https://dmicronutrients could also be administered enterally, this may have
underestimated the use of routine supplementation. Also, we did
not survey potassium monitoring and supplementation, which is
equally important in preventing and treating refeeding syndrome.
However, we expect that potassiummeasurements and subsequent
supplementation are more routinely implemented, since most
blood gas analyzers report potassium concentrations. Finally,
despite carefully checking face validity by the focus group, we
cannot exclude that some respondents unintentionally provided a
wrong answer for some questions.5. Conclusion
A substantial variation exists in monitoring and parenteral
administration of vitamins, trace elements, phosphate and mag-
nesium in critically ill patients. A considerable fraction of intensive
care specialists reported to not regularly monitor and/or paren-
terally administer these micronutrients and minerals in the early
phase of critical illness. The absence of routine monitoring and
parenteral supplementation in the early phase may lead to undi-
agnosed deficiencies and unrecognized refeeding syndrome, two
entities with non-specific symptoms that may potentially be lethal.
Moreover, the shift towards hypocaloric nutrition in the first days of
critical illness may increase the risk of developing deficiencies
when also micronutrients and minerals would be restricted,
although the optimal timing and dose of supplementation remains
to be investigated. Hence, besides opening perspectives for
comparative studies assessing the most optimal strategy regarding
micronutrient monitoring and administration, the survey identified
clear areas for knowledge translation.Statement of autorship
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